Thin, Fragile Skin, Bruising and Slow Healing: Hydrocortisone/Glucocorticoid Effects and the Possible Relevance of sPRP and BPCP

By

Focused summary. The combination of thin or fragile skin, easy bruising and slow wound healing is compatible with chronic glucocorticoid effects on skin. Dryness, wrinkles and sagging can occur in the same clinical picture, but they are less specific because aging, sun exposure, psoriasis and impaired skin-barrier function can produce similar changes. The key question is therefore not whether every symptom is caused by hydrocortisone, but whether cumulative glucocorticoid exposure is contributing to dermal atrophy and poor repair.

1. Why glucocorticoids can produce this skin pattern

Glucocorticoids can suppress fibroblast activity and collagen synthesis. With less dermal collagen and structural support, skin may become thinner, more translucent and easier to tear.

Reduced dermal support makes small blood vessels less protected, which can contribute to easy bruising or purpura.

Glucocorticoid exposure can impair normal tissue-repair processes, making wounds or skin tears heal more slowly.

Skin-barrier impairment can contribute to dryness and increased sensitivity. Wrinkling and sagging may become more visible when age-related collagen loss is superimposed on dermal thinning.

Older skin is particularly vulnerable because normal aging already reduces dermal thickness, elasticity and repair capacity.

2. The symptom cluster: what is more versus less specific

  

3. Hydrocortisone replacement: dose can be “standard” yet still require individual review

The source material notes that 20 mg/day hydrocortisone (15 mg on waking and 5 mg in the early afternoon) falls within a commonly used adrenal-replacement range and follows the usual principle of giving the larger dose in the morning. However, replacement is individualized. A dose that is conventional on paper does not exclude mild over-replacement in a particular person, especially when clinical features such as marked skin thinning, bruising and slow healing develop.

Important: hydrocortisone used for adrenal insufficiency should not be reduced or stopped without the treating endocrinologist. Under-replacement can be dangerous. The useful clinical question is whether the current dose is the lowest dose that still provides safe, adequate replacement.

4. Total glucocorticoid exposure matters

Systemic hydrocortisone is only one possible source. In a person with psoriasis, topical corticosteroids (for example, potent creams, ointments or scalp preparations) can add substantially to local skin thinning, particularly when used repeatedly or for long periods. Inhaled, nasal, injected and other steroid preparations should also be included when reviewing cumulative exposure.

5. Where sPRP and BPCP fit—and where the evidence stops

The attached article describes standard platelet-rich plasma (sPRP) and Balanced Protein-Concentrate Plasma (BPCP) in a human neuron–microglia model of neuroinflammation. Both formulations reduced inflammatory signaling, but they did so differently.

BPCP behaved mainly as a stronger suppressor of inflammatory signaling: it reduced major cytokines, microglial activation markers and apoptosis-related pathways.

sPRP showed a more pro-resolving/neuroprotective pattern: it increased IL-10 and TGF-β1 and restored KCC2 expression, suggesting support for inflammation resolution and neuronal recovery/plasticity.

The article's broader message is that the biological effect of a plasma preparation depends on its molecular composition, not simply on platelet concentration.

Crucial limitation for fragile skin: the cited sPRP/BPCP study is about neuroinflammation, not glucocorticoid-induced skin atrophy, bruising, xerosis, wrinkles, sagging or delayed wound healing. It therefore cannot establish that either BPCP or sPRP reverses hydrocortisone-related dermal thinning or is clinically effective for this skin problem.

6. A skin-focused hypothesis for future evaluation

From a mechanistic perspective, plasma-derived biologic preparations are of interest because tissue repair depends on coordinated inflammatory resolution, fibroblast activity, extracellular-matrix production, vascular support and growth-factor signaling. However, the neuroinflammation findings cannot simply be transferred to skin.

If sPRP or BPCP is being considered for thin, fragile, glucocorticoid-exposed skin, the clinically relevant questions would be different from those studied in the attached article: Does the preparation improve dermal thickness or collagen organization? Does it reduce bruising or skin tearing? Does it improve wound-closure time? Does it improve hydration/barrier function, wrinkles or laxity? And is it safe in older, inflamed or psoriasis-affected skin?

7. BPCP versus sPRP: what can currently be said 

 

8. Practical clinical focus

For the symptom pattern of dryness, wrinkles, thinning, sagging, bruising and slow healing, the priority is to identify modifiable causes before assuming that a regenerative injection can compensate for ongoing dermal injury. A dermatologist can distinguish xerosis and psoriasis-related barrier dysfunction from steroid-related dermal atrophy, actinic damage and senile/actinic purpura. An endocrinologist can review whether systemic hydrocortisone exposure is appropriately individualized.

The attached material also suggests considering CBC/platelets, coagulation testing, iron status, B12/folate, protein/albumin, metabolic and liver/kidney testing, vitamin D, thyroid testing, glucose/HbA1c, and selected nutritional/inflammatory tests when clinically appropriate, because bruising and poor healing can have multiple causes.

Bottom line

Thin/fragile skin + bruising + slow healing is a clinically coherent pattern that is compatible with glucocorticoid effects on the skin, especially when combined with long-term exposure and older age. Dryness, wrinkles and sagging may accompany the picture but are less specific. sPRP and BPCP have biologically different effects in the attached neuroinflammation study, but that study does not show that either treatment reverses glucocorticoid-related skin atrophy. Any proposed use for this purpose should therefore be framed as a separate, skin-specific therapeutic question requiring appropriate clinical evidence.

Source basis. Rewritten from the supplied document, with the emphasis shifted from neuroinflammation to the skin findings and to the limits of extrapolating sPRP/BPCP neuroinflammation data to dermatologic treatment.

References:

Platelet-Rich Plasma Modulates Neuroinflammation in an iPSC Model of Sensory Neurons and Microglia
https://www.mdpi.com/1422-0067/27/16/7127

 

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right.
Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Very Long-Chain Fatty Acids (VLCFAs) X-ALD and Spinal Muscular Atrophy (SMA): Exploring the Connection

By
Image
Introduction: White Brain Matter, VLCFAs, and X-ALD X-linked Adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder and a major cause of progressive neurodegeneration in children—sometimes referred to as “childhood dementia.” Across related conditions, prevalence can range from approximately 1 in 2,000 to 1 in 500,000 newborns. Among its forms, childhood cerebral X-ALD is the most severe, marked by rapid inflammatory demyelination in the brain and often fatal outcomes if not treated early. At the core of X-ALD is a disruption in the metabolism of Very Long-Chain Fatty Acids (VLCFAs). Normally, these fatty acids are broken down in peroxisomes—specialized structures within cells that help maintain metabolic balance. In X-ALD, a mutation in the ABCD1 gene impairs this function, causing VLCFAs to accumulate, particularly in the white matter of the brain, spinal cord, and adrenal glands. This accumulation leads to demyelination, adrenal insufficiency (Addison’s disease), an...
Read more

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By
Image
Important update: My experiences have now been formally verified following several years of dismissal. Vasculitis syndromes: the pathogenic roles of COVID-19 and related vaccinations https://link.springer.com/article/10.1186/s12985-025-03032-x  ----------------------------------------- Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially pres...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more

Polio and Post-Polio Syndrome (PPS): Summary and Key Insights

By
Image
  Abstract To investigate the possible role of poliovirus (PV) infection in the development of Post-Polio Syndrome (PPS), researchers studied serum, cerebrospinal fluid (CSF), peripheral blood lymphocytes, and muscle tissue from 47 PPS patients. Elevated IgM antibodies against poliovirus were identified in a subset of patients, with titers reaching 1:250 compared with less than 1:50 in healthy individuals and disease controls. Using polymerase chain reaction (PCR) techniques targeting the poliovirus replicase gene, PV RNA sequences were detected in peripheral blood lymphocytes from 7 of 37 patients and in the CSF of 4 of 40 patients, while no viral sequences were detected in controls. Sequencing confirmed a 99.3% homology with poliovirus type 1. These findings suggest that some PPS patients may exhibit an ongoing immune response to poliovirus antigens. The detection of poliovirus RNA raises the possibility of persistent mutated virus or defective viral particles. However, the signi...
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By
Update: New Research Builds on Previous Findings Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2832234?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=040925&adv= Conclusions: This recent cohort study builds upon earlier work by identifying COVID-related cytokine storm (COVID-CS) through common inflammation markers and comparing it with two other cytokine storm (CS) conditions: malignancy-associated hemophagocytic lymphohistiocytosis (MN-HLH) and CAR-T–associated cytokine release syndrome (CAR-T CRS) . Among the three groups, patients treated with CAR-T therapy showed the highest survival rates , in contrast to those with COVID-CS and MN-HLH. Interestingly, the study found that CAR-T CRS and COVID-CS share similar cytokine activation pathways , suggesting a comparable immune response mechanism. In c...
Read more

The Impact of Acids on Muscular and Vascular Systems: Potential Negative Outcomes

By
This is ongoing research, and updates will be included as soon as they become available. A kidney transplant recipient with acute SARS-CoV-2 infection developed rhabdomyolysis and severe acute kidney injury (AKI) . A muscle biopsy confirmed findings consistent with immune-mediated necrotising myositis. Acid exposure and acid–base imbalances may profoundly affect the muscular and vascular systems. Strong acids from external sources, such as industrial chemicals, can cause corrosive tissue damage, while internal disturbances associated with metabolic disorders may disrupt cellular function and contribute to systemic complications. This article explores the potential effects of external acid exposure and internal acid–base disturbances on muscular and vascular health, including those associated with metabolic or genetic conditions. Because susceptibility to ME/CFS and complications following COVID-19 varies among individuals, further research may help determine whether genetic variant...
Read more

Impact of Penicillium on Muscle and Lung Function: What Healthcare Professionals Should Know

By
Image
Introduction While symbiotic relationships between viruses and bacteria have been documented, the possibility of a symbiosis between COVID-19 (SARS-CoV-2) and common fungal genera such as Penicillium , Aspergillus , and Trichoderma remains unexplored. This gap in research presents a potential area of interest for understanding novel microbial interactions and their implications for human health. Symbiosis Between Viruses and Bacteria – A Fascinating Partnership in the Microbial World https://swaresearch.blogspot.com/2025/07/symbiosis-between-viruses-and-bacteria.html When viruses, bacteria, or fungi—such as Penicillium —enter a host, they can trigger a range of immune responses and physiological disruptions.  Penicillium molds do not directly produce autoantibodies. However, exposure to Penicillium mold and its mycotoxins can trigger an immune response that may lead to the production of IgG antibodies , including those that could be reactive against the body's own tissues ,...
Read more